| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1634.2B | ¥1558.2B | +4.9% |
| Operating Income | ¥124.8B | ¥102.6B | +21.7% |
| Ordinary Income | ¥138.8B | ¥112.4B | +23.5% |
| Net Income | ¥104.7B | ¥83.2B | +25.9% |
| ROE | 6.3% | 5.4% | - |
FY2026 Q3 results demonstrated strong profit growth despite modest revenue expansion. Revenue reached 163.4B yen (YoY +4.9%), Operating Income 12.5B yen (+21.7%), Ordinary Income 13.9B yen (+23.5%), and Net Income 10.5B yen (+25.8%). The quarter highlighted significant operating leverage, with operating margin expanding 106 basis points to 7.6% from 6.6% in the prior year. Gross margin improved to 29.6% driven by pricing actions, product mix optimization, and favorable foreign exchange effects. Non-operating income contributed 1.4B yen, including 0.7B yen in foreign exchange gains and increased interest and dividend income. Special items added 1.2B yen primarily from investment securities sales gains. The company maintained its full-year guidance of 235B yen revenue, 18.5B yen operating income, and 14.0B yen net income, implying Q4 operating income of approximately 6.0B yen to meet targets.
[Profitability] ROE of 5.6% represents an improvement from the prior year, driven primarily by net profit margin expansion of 82 basis points to 5.7%. Operating margin increased 106 basis points to 7.6%, reflecting improved gross margin of 29.6% and controlled SG&A expenses at 21.9% of revenue. ROIC stood at 4.4%, indicating room for improvement in capital efficiency. The DuPont decomposition shows ROE components of 5.7% net margin, 0.537 asset turnover, and 1.83x financial leverage. Interest coverage ratio reached 15.9x, demonstrating strong debt servicing capacity. [Cash Quality] Cash and deposits totaled 31.6B yen with short-term debt coverage of 0.94x. Working capital metrics show DSO of 102 days, DIO of 363 days, and cash conversion cycle of 410 days, indicating significant capital tied up in operations. [Investment Efficiency] Total asset turnover of 0.537 reflects the working capital intensity, with inventory increasing 29.9% YoY. Capital-in-progress ratio of approximately 10% indicates a balanced investment pipeline. [Financial Health] Equity ratio of 54.7% (versus 52.8% prior year) demonstrates solid capitalization. Current ratio of 223% and quick ratio of 178% indicate adequate short-term liquidity. Debt-to-equity ratio of 0.83x and net debt-to-capital of 29.9% position the balance sheet conservatively. Short-term liabilities represent 47.6% of total liabilities, with short-term borrowings increasing 41.4% YoY to 33.7B yen.
While quarterly cash flow statement details are not disclosed, balance sheet analysis reveals key fund movements. Cash and deposits increased 3.7B yen YoY to 31.6B yen despite significant working capital absorption. The 9.4B yen increase in inventory (29.9% YoY) and 10.2 days extension in receivables days outstanding indicate substantial operating cash demands. Short-term borrowings expanded 9.9B yen (41.4% increase) to fund working capital requirements, particularly the inventory buildup. The company's ability to generate 10.5B yen in net income while managing these working capital headwinds demonstrates underlying operational strength. The cash-to-short-term debt ratio of 0.94x suggests prudent liquidity management, though refinancing execution remains important given the elevated short-term borrowing base. Comprehensive income of 17.0B yen substantially exceeded net income, benefiting from positive foreign currency translation adjustments that strengthened equity by approximately 6.4B yen. The planned annual dividend of 165 yen per share (44.4% payout ratio) appears sustainable given the strong interest coverage and conservative leverage profile, though free cash flow generation will depend critically on working capital normalization in Q4.
Ordinary income of 13.9B yen compared to operating income of 12.5B yen reflects a net non-operating contribution of 1.4B yen, comprising primarily foreign exchange gains of 0.7B yen and increased interest and dividend income. Non-operating income represents less than 1% of revenue, indicating earnings are predominantly driven by core operations. Special items contributed 1.2B yen (6.3% of net income), consisting mainly of investment securities sales gains of 1.2B yen, representing a one-time benefit. The operating profit improvement of 2.2B yen YoY stemmed from margin expansion rather than volume leverage, with gross profit increasing 3.9B yen while SG&A grew only 1.7B yen. The company's working capital metrics signal earnings quality considerations: with DIO extending to 363 days and DSO at 102 days, the cash conversion cycle of 410 days suggests significant lag between profit recognition and cash realization. The 29.9% inventory increase outpacing 4.9% revenue growth raises questions about demand alignment and potential obsolescence risk. However, the underlying profit margin improvements across gross, operating, and net levels demonstrate genuine operational enhancement. The foreign exchange contribution of approximately 5% of operating profit adds modest volatility to recurring earnings power.
Inventory accumulation risk represents the most immediate concern, with inventory expanding 9.4B yen (29.9% YoY) to 40.7B yen and DIO reaching 363 days. This concentration of working capital in stock creates exposure to demand volatility, potential markdowns, and obsolescence charges. Given the project-oriented nature of electrical equipment and welding systems, work-in-progress buildup may reflect project timing, but sustained elevation warrants monitoring. Customer credit and collection velocity presents the second key risk, with DSO of 102 days and 10.2-day extension YoY indicating slower cash conversion. The 11.9B yen receivables increase (15.5% YoY) outpacing revenue growth suggests either extended payment terms or collection challenges that could stress operating cash flow. Refinancing and interest rate exposure constitutes the third material risk. Short-term borrowings increased 9.9B yen (41.4%) to 33.7B yen, elevating reliance on rolling short-term debt. With cash-to-short-term debt at 0.94x, the company requires continuous credit line access. Rising interest rates in Japan could materially impact financing costs given the short-term debt concentration, though current interest coverage of 15.9x provides substantial buffer.
[Industry Position] (Reference - Proprietary Analysis) Daihen's profitability metrics position the company near industry medians across most dimensions. Operating margin of 7.6% sits below the manufacturing sector median of 8.3% (IQR: 4.8%-12.6%), indicating room for operational improvement despite recent gains. Net profit margin of 5.7% approximates the industry median of 6.3% (IQR: 3.2%-9.0%). ROE of 5.6% aligns closely with the sector median of 5.0% (IQR: 2.9%-8.1%), while ROA of 3.4% matches the industry median of 3.3% (IQR: 1.8%-5.2%). Revenue growth of 4.9% YoY exceeds the sector median of 2.7% (IQR: -1.9%-7.9%), demonstrating above-average topline momentum. Financial health metrics show mixed positioning: the equity ratio of 54.7% falls below the industry median of 63.8% (IQR: 49.5%-74.7%), suggesting more aggressive capital structure despite conservative absolute levels. Current ratio of 223% substantially trails the sector median of 284% (IQR: 210%-381%), though remains adequate. Working capital efficiency represents a key divergence: DIO of 363 days significantly exceeds the industry median of 109 days (IQR: 50-155 days), highlighting inventory management as a critical improvement area. DSO of 102 days also surpasses the median of 83 days (IQR: 68-115 days), confirming below-average collection efficiency. The resulting cash conversion cycle of 410 days substantially lags typical manufacturing peers. Asset turnover of 0.537 falls below the sector median of 0.58 (IQR: 0.42-0.66), consistent with the working capital intensity observed. ROIC of 4.4% approximates the industry median of 5.0% (IQR: 3%-10%), indicating capital efficiency near sector norms but below best-in-class standards. (Industry: Manufacturing, N=98 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Profit margin expansion provides the primary positive signal, with operating margin improving 106 basis points to 7.6% and net margin advancing 82 basis points to 5.7% YoY. This demonstrates genuine operational leverage from pricing discipline, cost management, and favorable product mix, rather than purely volume-driven growth. The 21.7% operating income growth on 4.9% revenue growth confirms effective margin management and positions the company for improved profitability sustainability if maintained. Working capital intensity represents the critical improvement opportunity, with 410-day cash conversion cycle substantially exceeding industry norms and tying up significant capital. The 29.9% inventory increase and 15.5% receivables growth outpacing 4.9% revenue growth signal potential misalignment between production, sales, and collection cycles. Successfully normalizing these metrics could unlock substantial cash flow improvement and support higher return on invested capital. The Q4 trajectory toward full-year guidance appears achievable but hinges on execution, requiring approximately 6.0B yen in Q4 operating income to meet the 18.5B yen annual target. Historical seasonality and the improved margin profile support feasibility, but working capital normalization becomes essential to validate guidance and demonstrate sustainable cash generation capability heading into the next fiscal year.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.